首页> 外文期刊>JAMA: the Journal of the American Medical Association >Influence of airway management on ventilator-associated pneumonia: evidence from randomized trials (published erratum appears in JAMA 1999 Jun 9;281(22):2089)
【24h】

Influence of airway management on ventilator-associated pneumonia: evidence from randomized trials (published erratum appears in JAMA 1999 Jun 9;281(22):2089)

机译:气道管理对呼吸机相关性肺炎的影响:来自随机试验的证据(发表的勘误表见JAMA 1999 Jun 9; 281(22):2089)

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Ventilator-associated pneumonia (VAP) is a serious complication of critical illness, conferring increased morbidity and mortality. Many interventions have been studied to reduce the risk of VAP. We systematically reviewed the influence of airway management on VAP in critically ill patients. DATA SOURCES: Studies were identified through searching MEDLINE and EMBASE from 1980 through July 1997 and by searching SCISEARCH, the Cochrane Library, bibliographies of primary and review articles, personal files, and contact with authors of the randomized trials. STUDY SELECTION: We selected randomized trials evaluating ventilator circuit and secretion management strategies on the rate of VAP. DATA EXTRACTION: Two investigators independently abstracted key data on design features, the population, intervention, and outcome of the studies. DATA SYNTHESIS: The frequency of ventilator circuit changes and the type of endotracheal suction system do not appear to influence VAP rates (3 trials, none with significant difference; range of relative risks [RRs], 0.84-0.91). However, lower VAP rates may be associated with avoidance of heated humidifiers and use of heat and moisture exchangers (5 trials, only 1 showing a significant difference; range of RRs, 0.34-0.86), use of oral vs nasal intubation (1 trial; RR, 0.52; 95% confidence interval, 0.24-1.13), subglottic secretion drainage vs standard endotracheal tubes (2 trials, 1 showing a significant difference; range of RRs, 0.46-0.57), and kinetic vs conventional beds (5 trials, only 1 showing a significant difference; range of RRs, 0.35-0.78). CONCLUSIONS: Some ventilator circuit and secretion management strategies may influence VAP rates in critically ill patients. Whether these strategies are adopted in practice depends on several factors such as the magnitude and precision of estimates of benefit and harm, as well as access, availability, and costs.
机译:目的:呼吸机相关性肺炎(VAP)是严重疾病的严重并发症,会增加发病率和死亡率。已经研究了许多干预措施以降低VAP风险。我们系统地回顾了危重患者气道管理对VAP的影响。数据来源:通过搜索1980年至1997年7月的MEDLINE和EMBASE以及搜索SCISEARCH,Cochrane图书馆,主要和评论文章的书目,个人文件以及与随机试验作者的联系来鉴定研究。研究选择:我们选择了随机试验,评估呼吸机回路和VAP发生率的分泌管理策略。数据提取:两名研究人员独立提取了有关设计特征,总体,干预和研究结果的关键数据。数据综合:呼吸机回路改变的频率和气管内吸气系统的类型似乎不影响VAP率(3项试验,无显着性差异;相对风险范围[RRs],0.84-0.91)。但是,较低的VAP率可能与避免使用加热的加湿器以及使用热湿交换器有关(5项试验,只有1项显示出显着性差异; RR的范围为0.34-0.86),使用口服或经鼻插管(1项试验;相对危险度(RR)0.52; 95%置信区间0.24-1.13),声门下分泌物引流与标准气管插管(2试验,1显示显着性差异;相对危险度范围(0.46-0.57)),以及动力学床与常规床(5试验,仅1显示出显着差异; RR范围为0.35-0.78)。结论:某些呼吸机回路和分泌物管理策略可能会影响危重患者的VAP发生率。在实践中是否采用这些策略取决于几个因素,例如收益和损害估计的大小和精确度以及获取,可用性和成本。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号